Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...
News Medical on MSN22h
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancerOne-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...
Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...
New research provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and ...
T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.
A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory ...
Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback